BCAL Diagnostics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
BCAL Diagnostics has a total shareholder equity of A$8.6M and total debt of A$641.3K, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are A$12.3M and A$3.7M respectively.
Anahtar bilgiler
7.5%
Borç/özkaynak oranı
AU$641.34k
Borç
| Faiz karşılama oranı | n/a |
| Nakit | AU$6.47m |
| Eşitlik | AU$8.59m |
| Toplam yükümlülükler | AU$3.68m |
| Toplam varlıklar | AU$12.27m |
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: BDX's short term assets (A$9.3M) exceed its short term liabilities (A$2.6M).
Uzun Vadeli Yükümlülükler: BDX's short term assets (A$9.3M) exceed its long term liabilities (A$1.1M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: BDX has more cash than its total debt.
Borcun Azaltılması: BDX's debt to equity ratio has increased from 0% to 7.5% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: BDX has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: BDX is forecast to have sufficient cash runway for 12 months based on free cash flow estimates, but has since raised additional capital.